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Cell-cell  interaction is a basic topic in biological sciences.  In embryogenesis, 
a  largely unsolved problem is the means by which cell-cell  recognition,  neces- 
sary for the build up of a  normal tissue,  is mediated  (1).  Under pathological 
conditions  this  hitherto  unrevealed  mechanism  of physiological  interactions 
seems to be lost.  In immunology numerous phenomena are based on cell-cell 
interactions.  Thus,  it  is,  for  instance,  well  accepted  that  cell  cooperation  is 
required for the induction of an antibody response in B  cells  (2), as well as for 
the sensitization  of T  cells  (3).  In addition,  the action of activated  T  cells on 
target  cells  is obviously a  cell-cell  interaction  phenomenon  (4).  Macrophages 
are an essential participant in some of these interactions  (5). 
In  this  paper  we  want  to  outline  in  detail  some  mechanisms  by  which 
complement components might play a role in these cell-cell interaction phenom- 
ena. It will be demonstrated that complement factors located on one cell can be 
induced by enzymes on adjacent cells to form a bridge between these two cells. 
Materials and Methods 
Chemicals and Reagents.  Trypsin, soybean trypsin inhibitor (SBTI), 1 and tannic acid (Merck 
A. G.,  Darmstadt, W. Germany). Except for C1 (guinea pig serum) the complement components 
used  were  from  human  serum.  The  components  C1,  C4,  and  C2  were  purified  to  functional 
purity.  C3 and C5 were purified to chemical purity by the method described by Tack and Prahl 
(6) applying polyethylene glycol during the initial step of the purification procedure. For some 
experiments we used labeled C3, the third component of the complement system with 1~I (C3 x) 
(7). C3b was generated from C3 or C3  x according to Bokisch et al.  (8). After completion of the ex- 
periments reported in this paper, for comparison, C3 was prepared by a  method that avoided the 
use of polyethylene glycol (see Discussion). 
Buffers.  Isotonic veronal-buffered saline (VBS) pH 7.4, containing 1.5 x  10 -4 M Ca  ++ and 1 × 
10 -3 M  Mg  ++ was used as a  general diluent for complement components and the sensitized and 
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Abbreviations used in  thispaper: C1, C2, C3, C4, and C5, first  five  components of  complement; 
C3RC, C3 receptor-carrying cell;  C3x, third  component of  complement labeled with 125I;  C4-~,  C3 
convertase; Ci,  activated C1;  EA,  sensitized sheep  erythrocytes; EAC1,  EAC14,  EAC142, 
EAC1423b, and EAC43b, EA coated with human complement components; EAC43d  h", EAC43b hu 
treated with a C3b inactivator  reagent; ~an, tannic acid-treated  sheep erythrocytes;  E~n-trypsin, 
trypsin-charged E~"; LBS, labile  binding site  on nascent C3b; PBL, peripheral blood lymphecytes; 
SBS1 or SBS2, stable  binding site  one or  two on the C3 molecule; SBTI, soybean trypsin inhibitor; 
VBS, veronal-buffered saline. 
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complement-coated erythrocytes. Eagle's MEM pH 7.2 (Autopow Flow Laboratories, Bonn) was 
used as a general diluent for lymphocytes. 
Cells.  Cells from three different human cell lines, Raji, Daudi, and Rael (culture seeds were 
kindly supplied by Dr. G. Klein, Stockholm),  all derived from Burkitt lymphoma, were grown in 
RPMI 1640 (Grand Island Biological  Co., Grand Island, N.  Y.) supplemented with glutamine, 
nonessential  amino acids, pyruvate, 10% fetal calf serum, penicillin;  streptomycin, and Fungizone 
(9). Cells taken from mid-log phase cultures (5-8  x  105 cells/ml) were washed once with MEM, 
resuspended in MEM,  and adjusted to a  concentration of 2  x  105 cells/ml. Cell viability was 
assessed by the uptake of trypan blue. 
Human peripheral blood lymphocytes from normal individuals  were prepared from heparinized 
blood (10). Granulocytes were obtained from guinea pigs after intraperitoneal glycogen stimula- 
tion. Sensitized sheep erythrocytes (EA), EAC1, EAC14, EAC142, EAC1423b, and EAC43b were 
prepared from sheep erythrocytes, rabbit anti-sheep hemolysin (Behring-Werke, AG, Marburg/ 
Lahn, W.  Germany), and purified complement components (11). For the preparation of C2a- 
containing  intermediates in all cases oxidized C2 was used to generate C~ enzymes with a much 
greater stability (12); the half-life time of the intermediates used was about 30 min. Nonoxidized 
C2 was used only to prepare EAC43b. EAC43d were obtained from EAC43b by treatment with a 
C3b inactivator reagent (13). Before use, the cells were washed three times in VBS and adjusted 
to a concentration of 1.3 x  l0  s cells/ml VBS. 
Trypsin-charged sheep erythrocytes were obtained by incubating equal volumes of a  2.5% 
erythrocyte (E)-suspension in VBS and a 5% tannic acid solution (in 0.9% sodium chloride) for 10 
rain at 37°C. After washing (700 g,  10 vain) and resuspending, the tannic acid-treated sheep 
erythrocytes (E  ~") were mixed with equal vol of solutions of 5-50 mg trypsin/ml VBS, rotated for 
12 h at 4°C, washed three times with VBS, and adjusted to a concentration  of 1.3 x l0  s cells/ml in 
VBS. For control, trypsin solutions were replaced by buffer. 
Rosette Formation.  The reaction mixture, consisting  of 200 ~1 Raji cells (2 x  10e/ml MEM) + 
200 ~1 EAC1423b (1.3 x  108/ml VBS), was put into 1-ml plastic beakers (Eppendorf,  Hamburg) 
and rotated on a submersion rotator for 20 rain at 37°C. The rosette formation tests with other 
lymphocytes and intermediates were performed  as described for Raji cells and EAC1423b. 
Bridge Formation Assay.  The test consisted of two steps: as a first step 200 ~1 of a suspension 
of Raji cells or other leukocytes (= step I cells) (2 × 105/ml) were preincubated with a solution of 
a complement factor (C3, C5, C4, or C1) or buffer in Eppendorf tubes for varying time periods at 
varying temperatures (see Results). Then the cells were washed four times in MEM (10 rain, 400 
g) and finally resnspended in 200 ~1 MEM. 
As a second stop,  these 200 ~l of pretreated cells were mixed with 200 /~1 of a suspension of 
either EAC142, other intermediates, or trypsin-charged E  ~"  (E~"-trypsin) (step II cells) (1.3 x 
los/ml). After rotating this mixture for up to 20 rain at 37°C on a submersion rotator, cell-cell 
interaction was determined by enumerating rosettes which had been formed between one step I 
cell and three or more step II cells. The standard deviations were usually less than 10%. 
Results 
Formation  of Complement  Bridges  between  Cells  by  the  Exclusive  Use  of 
Factors of the Complement System 
C3  BRIDGES:  BINDING  OF  EAC142  TO  C3  RECEPTOR  CELI.~  (C3RC),  CARRYING  UN= 
CLEAVED  C3.  EAC1423b and EAC1423d can be  attached to  cells carrying re- 
ceptors for the stable binding site (SBS1) on C3b or for the stable binding site 
(SBS2) on C3d (13,  14). In this case,  C3 is used in its fragmented form, C3b or 
C3d,  with both  fragments  bound to  EAC142  through  the  labile binding site 
(LBS), which is transiently present on freshly generated C3b (15).  In contrast 
to this standard procedure, C3-dependent interlinkage of cells can be induced 
by reversing the sequence of events, as shall be demonstrated in the following 
experiments.  200  /~l  of a  suspension of lymphocytes, human  PBL  as  well  as 
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FZG. i.  Binding of  EACI42 to  leukocytes,  carrying uncleaved C3.0.4 x I0  ~  leukocytes in 
200 ~l MEM  were preincubated (20  rain,  37°C)  with increasing amounts of  C3, washed four 
times, resuspended in 200 /~I MEM,  and tested  for rosette formation with 200 /~l of a 
suspension of  EAC142 (1.3 x 10S/ml). 
were preincubated for 20 min at 37°C with 10-300 ~1 of a solution of uncleaved 
C3  (2.5 mg/ml).  After  this  incubation  the  cells  were  washed  four  times, 
resuspended in 200 ~l MEM, and mixed with 200 pl of a suspension of EAC142 
(1.3  x  10S/ml; carrying on an average 1.5 hemolytic sites of C2a per EAC142). 
This mixture was incubated in a submersion rotator for 20 rain at 37°C. For the 
Raji cells the experiments were performed with C3,  which had been labeled 
with l~I to determine the amount of C3 molecules bound per cell. Fig. 1 shows 
the results. 
Incubation  of the  different leukocytes with  increasing  concentrations of 
uncleaved C3 led to interlinkage of the C3RC and EAC142 as revealed by an 
increasing percentage of rosette formation between the  C3RC and EAC142. 
Raji cells reached a  saturation point at high C3  concentrations (2×  107  C3 
molecules/cell resulting from incubation of the Raji cells with 200 ~g C3). More 
C3 did not lead to increased binding of EAC142. Within the C3 concentrations 
which were applied,  guinea pig polymorphonuclear leukocytes, human PBL, 
and Rael cells also appeared to reach their maximal reactivity. Daudi cells 
behaved differently from the other cells.  Even after incubation in  solutions 
with a high C3 concentration they reacted weakly. 
The control experiments, i.e. preincubation of the C3RC in medium instead 
of C3, resulted in less than 5% rosette formation except for the granulocytes of 
which 15% rosetted directly with EAC142. To rule out the possibility that the 
interaction between Raji-C3 cells and EAC142 was due to C3, which detached 
from the Raji cells, reacted with EAC142, and only then mediated classical C3- 
dependent rosettes,  the following experiments were performed.  0.5  ml  of a MANFRED  P.  DIERICH  AND  BEATE  LANDEN  1487 
suspension of  Raji  cells  (2 x 10e/ml)  was preincubated (20 rain,  37°C)  with 0.5 
ml of a C3 solution (2.5  mg/ml), washed four times, resuspended in 0.5 ml 
MEM,  and incubated for additional  20 min at 37°C. 200 ~l of  the supernate of 
this incubation mixture was offered  to 200 ~l of  a fresh Raji  cell  suspension. 
These cells  were processed as  above, but  no C3-dependent interlinkage  between 
Raji cells  and EAC142 was observed. This fitted  well with the fact  that Raji 
cells  which had been loaded with 1251-C3~  (20 vain,  37°C),  washed four  times, 
and incubated again at 37°C for 20 rain  hardly released any C3  ~ during this 
secondary incubation. 
TIME  AND  TEMPERATURE  DEPENDENCE  OF  THE  C3  BINDING  TO  C3RC:  The C3- 
induced interlinkage between C3RC and EAC142  was not only dependent on 
the concentration of C3  but also on the time and temperature of the period 
during  which  the  C3RC were  exposed  to  C3.  This  was  demonstrated by 
incubating 200  ~1 of a  Raji cell suspension  (2  ×  106/ml) with 100  ~1 of a  C3 
solution (2.5 mg/ml) for 1-40 rain at 37°C and for 20 min at 4°C  up to 37°C. 
Then the cells were washed four times and reacted with EAC142 as described 
in the previous chapter (Fig.  2). After 20 min at 37°C the maximal C3 effect on 
Raji  cells  was  reached,  which  in  a  secondary incubation  allowed  optimal 
attachment of EAC142 (70% rosetted cells).  Prolonging the preincubation by 20 
min was disadvantageous, i.e.  it resulted in 20% less rosette formation. The 
temperature effect was clearly demonstrable, in that increasing temperatures 
led to increasing C3 effects, namely from 10% rosettes after preincubation at 
4°C to about 80% rosettes after incubation at 37°C. 
ESSENTIAL  ROLE  OF  UNCLEAVED  C3  FOR  THE  C3-DEPENDENT  BRIDGE  FORMA- 
TION.  The  experiments  performed  thus  far  were  compatible  with  the 
assumption that the two stable binding sites of C3 (SBS1 and SBS2) as well as 
the LBS are involved in the C3-dependent bridging reaction. To check directly 
for the relevance of the LBS we applied C3b, which had been generated in the 
fluid phase and thus had been deprived of LBS. 200 pl of a Raji cell suspension 
was incubated (20 rain, 37°C) with increasing amounts of radiolabeled C3b x or 
C3  ~,  respectively. After the cells had been washed, they were reacted with 
EAC142 and in parallel experiments with EAC1423b (Fig. 3). 
As demonstrated in Fig. 3, C3b was unable to modulate the lymphoid cells so 
that they would bind  EAC142  effectively. Nevertheless C3b  was capable of 
occupying the C3 receptors on Raji cells so that they did not form rosettes with 
EAC1423b anymore. In contrast, while also blocking the C3 receptors, C3  was 
able  to  induce  binding  of EAC142  (see  also  Figs.  1  and  2),  stressing  the 
importance of uncleaved C3 for the binding reaction. 
C5  BRIDGES:  BINDING  OF  EAC142,  EAC1423B~ AND  EAC43B/D  TO  C3RC-CARRYING 
o5.  The  discovery of the  C3-dependent bridges  stimulated  the  interest  in 
searching for a  role of other complement components. This paragraph deals 
with C5. In the same manner as for C3, the Raji cells were incubated with a C5 
solution (5 mg/ml) and then tested with different intermediates (Fig. 4). Great 
care was taken to assure that C5 was free of C3.  Thus, even if the C5 pools 
used were highly concentrated no precipitation with anti-C3 serum could be 
observed. At the same time in hemolytic assays no C3 could be found. 
As  depicted in  Fig.  4:EAC142  bound  to  Raji  cells  best  with  increasing 
amounts of C5 offered during the preincubation period. Without modulation by 1488  COMPLEMENT  BRIDGES  BETWEEN  CELLS 
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FIG. 2.  Time- and temperature-dependence of C3-induced bridging between Raji  cells 
and EAC142.0.4 × 106  Raji  cells  in  200/zl  MEM  were incubated for 1-40 rain  at  37°C and 
for  20  rain  at  4°-37°C  with 100/zl  of  a C3 solution  (2.5  mg/ml), washed  four  times  and  tested 
for  rosette  formation with EAC142. 
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FxG.  3.  Essential role of uncleared C3 for the C3-dependent bridge formation.  Samples of 
0.4  x  10  e Raji  cells in 200  ~l MEM were incubated  (20  rain,  37°C)  with radiolabeled C3 x 
(  )  or  C3b  ~ (  .....  ),  respectively,  washed  four  times  and  resuspended  in  200/zl  MEM. The 
Raji cells,  carrying different  amounts of C3 or C3b molecules per cell,  were tested  for 
rosette  formation  with EAC142. For  controls,  rosette  formation tests  with EAC1423b were 
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FIG. 4.  C5-induced interlinkage between Rsji cells  and different  EAC  intermediates. 
~amples of  0.4 × 10  ~  Raji  cells  in  200/A  MEM  were incubated  with  increasing amounts of  C5 
for 20 rain  at 37°C, washed four times, resuspended in 200 ~I MEM  and tested  for  rosette 
formation with various EAC  intermediates. 
C5 no attachment occurred. In contrast to this result, EAC1423b, EAC43b, and 
EAC43d behaved differently. They bound, as expected, to Raji cells which had 
not been exposed to C5. With all three intermediates this binding was decreased 
by preincubation of Raji cells with C5. In the case of EAC1423b and EAC43b, 
formation of about 70% rosettes was lowered to about 35%, whereas in the case 
of EAC43d rosette formation was reduced even further. EA and EAC14 did not 
support CS-dependent cell-cell interlinkage. 
DEPENDENCE  OF C3- AND C5-BRIDGES ON THE CONCENTRATION  OF  C~  ENZYMES 
PER EAC142.  In the preceeding chapters it was demonstrated that bridge for- 
mation between C3- or CS-coated Raji cells and EAC142 clearly depended on 
the concentration of C3 (Figs. 1 and 3) or C5 (Fig. 4). The following experiments 
shall clarify the importance of the concentration of C42 sites per EAC142. Raji 
cells were incubated (37°C, 20 rain) with an optimal amount of C3 (correspond- 
ing to 4  ×  1~ Raji cells +  250 ~g C3 in a vol of 300/A) or C5 (4 x  10  ~ Raji cells 
+  500 ~tg C5 in 300/~1), washed four times, and resuspended to 2 ×  106 cells/ml. 
Samples of these suspensions were then tested in the bridge formation assay 
with EAC14, which had been prepared with various concentrations of oxidized 
C2. 
The results show (Fig. 5) that the concentration of C42 enzymes per EAC142 
determined the degree of bridge formation with C3-  or C5-coated Raji  cells. 1490 
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FIG. 5.  Dependence of the bridge formation between C3- or CS-coated Raji  cells  and 
EAC142 on the amount of  C~  enzymes per EAC142. Samples 0.4 x 106 C3- (O  O) or 
C5- (O  i) coated Raji  cells  (in 200 pl MEM)  were mixed with 200 ~I of  EAC14 (1.3 x 
108/mI),  to  which  various amounts of  C2 had  been  attached (abscissa).  After 20  rain  at  37°C 
the  percentage  of  rosette  formation (ordinate)  was enumerated. 
EAC142  with low numbers of hemolytically active C42 enzymes seemed to 
cooperate more effectively  with C3-coated Raji  cells  than with cells  coated with 
C5. At higher C42 concentrations  this  was less  obvious. 
C4  BRIDGES:  BINDING  OF  EAC1  TO  C3RC-CARRYING  C4.  To  investigate the 
potential  role  of  C4, Raji  cells  were preincubated with a C4 solution  (5 mg/ml) 
and then tested with a suspension  of EA,  EAC1  (carrying about 300 C1 
molecules per cell),  EAC14, EAC142, and EAC1423b (1.3  x 10S/ml).  The results 
are described in Fig. 6. For controls  Raji cells  were preincubated  in buffer 
instead of  C4. 
In the absence of  C4, Raji  cells  formed rosettes  with EAC1423b (70%),  EAC1 
(30%),  and EAC14 (15%),  whereas the interaction  with EAC142 (5-7%) and EA 
(5%) was very weak.  Preincubation  of Raji cells  with C4 led to differing 
patterns for  the different  intermediates. Increasing C4 concentrations  resulted 
in decreasing percentages of  rosettes  between Raji  cells  and EAC1423b while 
the interaction  of  Raji cells  with EAC1, EAC14, and EAC142 was improved in 
a dose-dependent fashion.  EAC142 responded at  lower C4 concentrations  on the 
Raji cells  with an increase of rosette  formation  as did EAC14 or especially 
EAC1, the latter  needing about 10 times as much C4 during the preincubation 
to show  a noticeable reaction. EA  remained  unaffected even at high C4 
concentrations. 
C1  BRIDGES:  BINDING  OF  EA  TO  CELLS  CARRYING  C1.  The  data  depicted  in 
Fig.  6  shows  that  Raji  cells  did  not  interact with  EA but  with  EAC1  and 
EAC14.  Here the reaction sequence is reversed and Raji cells are coated first MANFRED  P.  DIERICH  AND  BEATE  LANDEN  1491 
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FIG. 6.  C4-induced  interlinkage between Raji  cells and different EAC  intermediates. 
Samples of 0.4 x 10  e  P~i cells in 200/~] MEM were incubated with increasing amounts of C4 
for 20 rain at 37°C, washed four times, resuspended in 200/~l MEM, and tested for rosette 
formation  with various  EAC intermediates. 
TABLE I 
Cl-Induced Bridge Formation between Raft Cells and EA 
~g CI incubated with Raji 
cells  Rosette formation 
% 
0  5 
18  18 
36  22 
54  27 
with C1 and then interacted with erythrocytes.  The dependence of the bridge 
formation on the dose of C1 is described. 
200 ill of a Raji cell suspension (2 x  106/ml) was incubated with 100-300 ~l of 
a  C1  solution  (360  ttg/ml).  After  15 min  at  37°C  the  cells were washed four 
times,  resuspended  in  200  ill  MEM,  and  run  in  the  rosette  assay with  EA 
(Table  1).  Table  1  shows  that  C1,  in  a  dose-dependent  fashion  mediated 
interaction of EA with Raji cells. If EA was replaced by E, a  reaction was not 
observed. 
Induction of Complement Bridges by the Use of an Unspecific Protease.  In 
the  experiments  outlined  in the preceeding paragraphs,  cell-cell interactions 
were  described,  which  were  based  on  the  cooperation  between  uncleaved 
complement  components  (C3,  C5,  and  C4)  and  enzymes  of the  complement 
system,  such  as C~-and  CT.  It is assumed that  activation  of the  uncleaved 
complement factors was essential for the reaction.  Since in fluid phase systems 1492 
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FIG.  7.  Bridge formation  between  Raji cells coated with complement  factors and E t~ 
carrying trypsin. Left part: Raji cells  coated with C3 were tested for  rosette formation with 
E t~ carrying different amounts  of trypsin.  For control  Eta-trypsin  were treated with 
SBTI. Right part:  Samples of  0.4 × 106  Rsji  cells  in 200/~l MEM  were incubated (20 rain, 
37°C) with increasing amounts of C3, C5, or C4, respectively,  washed four times,  resus- 
pended in 200 ~l MEM  and tested  for  rosette  formation with Emn-trypsin (prepared with a 
trypsin solution  of  20 mg/ml). 
unspecific proteases have been used to activate complement components (8, 16, 
17), we investigated the possibility that complement-dependent  bridge forma- 
tion could also be induced by an unspecific protease like trypsin. Therefore 200 
/~1 of a Raji cell suspension (2 x  10~/ml)  was incubated with an optimal amount 
of C3  (100 ftl of a  C3 solution of 5 mg/ml) for 20 rain at 37°C. When the cells 
had  been washed four times,  they were  resuspended in  200  ~1  MEM  and 
incubated in the rosette assay with 200 ftl of a suspension of Etan-trypsin (1.3 × 
108/ml). The Eta"-trypsin had been prepared by using different concentrations 
of trypsin. For control, trypsin inhibitor solutions were added to the reaction 
mixture (Fig. 7). 
As  demonstrated in  Fig.  7,  increasing trypsin concentrations during the 
preparation of E~"-trypsin led to higher activity in the bridge formation assay. 
But  concentrations above 20  mg trypsin/m] resulted in  pan-trypsin,  which 
showed a lower reactivity. In all instances the trypsin inhibitor, the concentra- 
tion of which in each case marked the original trypsin concentration, was able 
to block the reaction completely. To demonstrate that this reaction was clearly 
dependent on C3 and could also be induced with other complement components Z 
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FIG.  8.  Time-dependence  of the  interlinkage  between  C3-coated  Raji  cells  and  E  ~n- 
trypsin.  Raji cells coated with C3 were incubated for 1-20 min at 37°C with E~n-trypsin 
(prepared with a  trypsin solution of 20 mg/ml) to determine the rosette formation profile. 
such as C5  or C4,  samples of Raji cells were incubated with C3,  C5,  or C4, 
respectively. The different sets of cells were washed four times and every cell 
sample was resuspended in 200 ftl MEM. These cell samples were then mixed 
with 200  ~l of ]Etan-trypsin (1.3  x  10s), which had been prepared with 20 mg 
trypsin/ml. 
After rotation for  10  min at  37°C rosettes  were enumerated (Fig.  7).  As 
demonstrated in Fig. 6, dependent on the concentration of C3, C5, or C4, with 
which the Raji cells had been preincubated, rosettes were formed. C3 and C5 
were about identical with respect to their capacity to support this interaction 
(65-75% rosettes). C4 reacted weaker and induced only up to 20% rosettes. 
The interaction of Etan-trypsin with Raji-C3  was time-dependent. Raji-C3, 
prepared as for the experiments depicted in Fig. 6, and EtCh-trypsin, prepared 
with  20  mg trypsin/ml,  were incubated at  37°C for 1-20  min  (Fig.  8).  The 
reaction was optimal afar 10 min and decreased clearly from there on. 
Discussion 
The  data  presented  above  show  that  complement components can  form 
bridges between cells:  once uncleaved complement factors like C3,  C5,  or C4 
had been attached to cells carrying appropriate receptors, proteases on adjacent 
cells were able to activate these factors so that they acquired the capacity to 
anchor the complement factor-carrying cell to the protease-carrying cell. Thus, 
complement__  factors and proper proteases formed bridging units like: C3 + C4-~, 
C5  +  C42, and C4  +  C1.  In addition to these pure complement formations, 
units could be built from C3, C5, or C4 plus an unspecific protease like trypsin 
and from C1+  antibody.  The analysis of this  mechanism has  to provide  an 1494  COMPLEMENT  BRIDGES  BETWEEN  CELLS 
explanation  for the binding of uncleaved complement factors to the surface of 
the  different  cells  and  for  the  protease-induced  activation  of these  factors 
resulting in a  complement bridge. 
The binding of the uncleaved complement factors to cell surfaces is not yet 
completely understood.  C3,  C5,  and  C4  are  attached  at  least  in  part  to  C3 
receptors since, once they are bound to C3RC, the latter form less rosettes with 
EAC1423b  (Figs.  3,  4,  and  6)  indicating  impaired  C3  receptor function.  But 
besides the binding  to C3 receptors,  complement factors are possibly fixed to 
other sites, since Rael cells, which form no rosettes with EAC1423, are capable 
of binding  C3 so that  C3-dependent bridges can  arise  (Fig.  1).  Irrespective  of 
the site on the cell surface,  it appears  to be critical to bind C3 in the proper 
way.  Daudi cells,  having  C3d receptors,  can attach  C3 via its stable binding 
site two, SBS2 (located on the C3d part)  (14), but are unable to give rise to C3- 
dependent bridges (Fig. 1). Thus, it seems to be of major importance to bind C3 
through its SBS1 (associated with the C3c part)  (14) to C3b receptors, possibly 
to  leave  the  C3a  end  freely  accessible  (see  scheme  below).  It  should  be 
mentioned here that binding of uncleaved, purified C3 to C3RC is in contrast to 
the  fact that  uncleaved  C3  in  whole serum  does not bind  to  C3RC.  But we 
observed  that  during  the  C3  purification  C3  gained  this  binding  capacity 
(unpublished results). The fact that this occurred early during the C3 purifica- 
tion procedure argues against partial denaturation of C3 and favors separation 
of C3 from factors which cover it as an explanation for the binding.  The same 
consideration  may  hold  true  for  C4  and  C5.  The  possibility that  for the  C3 
reactions  discussed here  C3b might  be responsible  was ruled  out,  because it 
could be shown that C3b was able to bind to C3 receptors but unable to mediate 
bridge formation (Fig. 3). The amount of C3 molecules that could be attached to 
the C3RC (Fig.  3) was repeatedly found to be surprisingly  high,  especially in 
comparison  to  an  earlier  report  (18),  suggesting  that  binding  of C3  to  Raji 
cells  was  limited  to  about  5  ×  105  molecules per  cell.  However,  in  detailed 
binding studies even with highly concentrated C3 solution,  we were unable to 
reach  a  clear saturation  point  (unpublished  data).  Comparing  the  potency of 
isolated C3 to induce bridge formation (Raji-C3 + EAC142) or to inhibit rosettes 
between Rvji cells and EAC1423 it was observed that those concentrations of C3 
which allowed complete inhibition of rosette formation were also the concentra- 
tions allowing maximal bridge formation. In this context it is of interest that in 
the report cited above (18) amounts of C3 were needed for complete rosette inhi- 
bition which were similar to those used in our experiments for optimal bridge 
formation  (Fig.  1).  We would like  to add,  that  C3 purified  in  different ways 
might behave differently.  Thus,  for the preparation  of C3 used in the experi- 
ments  reported  here,  we  used  polyethylene  glycol,  following  the  method  of 
Tack  and  Prahl  (6).  After  completion  of the  experiments  reported  here  we 
prepared  C3,  starting  with  separation  of  euglobulins  and  pseudoglobulins 
instead of using polyethylene glycol. Such a  C3 shows the same reactions with 
respect to bridge formation as well as rosette inhibition but only about 1/5-1/lo 
of the amount of C3 is necessary for the same degree of response (unpublished 
results). 
The binding of C3 to the C3RC so that C3 can support bridge formation was a MANFRED  P.  DIERICH  AND  BEATE  LANDEN  1495 
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C : C4/C3  / C5  ( see  results  ) 
FIG.  9.  Complement bridges between cells: scheme of the suggested mechanism. Surface 
proteases (~)  liberate LBS (~)  on complement factors (C), which mediate the bridge 
formation. 
time- and temperature-dependent  process (Fig. 2). Although C3 was bound to C3 
receptors at 4°C (19), higher temperatures during the preincubation resulted in 
more bridges.  In analogy to requirements of the rosette formation (19),  it is 
reasonable to assume that the higher temperature was required to allow the 
lateral mobility of the C3 receptors, so that after binding of C3 they could gather 
in  patches and eventually in  caps.  This  may be  advantageous only up to  a 
certain point  beyond which it  could possibly  result in  a  smaller number of 
bridges as demonstrated by fewer rosettes after prolonged incubations at 37°C 
(Fig. 2). 
The activation of the surface-bound C3 to form bridges most likely occurs in 
the  same manner as  activation of C3  in  the fluid phase:  C3  on one cell is 
cleaved by the C4-2 enzyme on an adjacent cell into C3a and C3b; the LBS on 
C3b is liberated and anchors the surface-bound C3b onto the adjacent cell, thus 
interlinking  the  two  cells  (see  model  in  Fig.  9).  It  can  be  assumed  that 
numerous C3 molecules have to participate to make it an effective reaction. 
Thus far we cannot produce direct evidence that proteolytic cleavage of the 
surface-bound C3 molecules is essential. But the simultaneous requirement of 
the complement components and of the proteolytic activity (Figs. 4-7) for the 
bridge formation to occur leaves no doubt. This mechanism is not restricted to 
units  consisting of C3  +  enzyme but  functions also with other complement 
factors. Thus, surface-bound C5 can be activated by the C42 enzyme to interlink 
the C5 carrier with the carrier of C42,  so that the unit consists of C5  +  C42 
(Figs. 4 and 5). As the underlying mechanism we propose cleavage of C5 into 
C5a and C5b, the latter remaining attached to the cell but exposing an LBS. 
This LBS, as in the case of nascent C3b, would then anchor the C5b-carrying 
cell to the protease-carrying cell (see model in Fig. 9).  The cleavage of C5 by 
activated  C2  is  well  established  for  the  classical  activation  sequence as  it 
occurs  in  erythrocyte  lysis  (20),  although  in  the  classical  pathway  C3b 
(EAC1423) is needed probably to locate C5 close to the membrane and possibly 
to alter C5 so that it can be cleaved by C2. At first glance, these requirements 
seem not to be fulfilled under the special conditions of the bridge formation 
experiments. But it is not at all clear that binding of C5 to the surface of the 
lymphoblastoid cells might not possibly result in such an alteration of C5 so 
that it now can be cleaved by C2. It has also to be kept in mind that the EAC142 
used in our experiments could possibly carry a small number of C3b molecules 1496  COMPLEMENT  BRIDGES  BETWEEN  CELLS 
which cannot be detected hemolytically but which could serve as initial attach- 
ment sites  for the membrane-bound C5.  The binding of C5  to the lymphoid 
cells in all likelihood involves the C3 receptors, since after incubation of C3RC 
with  C5  the  C3RC form less  rosettes with  EAC1423b (Fig.  4).  In  addition, 
E-C5 form rosettes with Raji cells and these rosettes can be inhibited by C3 
(unpublished data; a detailed account of the C5 binding modalities will appear 
separately).  If  one  accepts  C5  binding  to  C3  receptors  then  one  would 
expect that C3-dependent rosette formation would be blocked completely by 
high C5  concentrations. But blocking of C3b-dependent rosette formation is 
possible only to a  certain degree and then reaches a  plateau (EAC1423b and 
EAC43b  in  Fig.  4).  One  explanation  might  be  that  uncleaved  C5  while 
occupying the C3 receptors is capable of binding to C3b. The bridging unit thus 
would consist of C5  +  C3b. This is supported by the fact that EAC43d  do not 
interact with Raji-C5  (Fig. 4). 
With respect to C4 a proper bridging unit appears to consist of C4 + Ci (Fig. 
6). In the course of these experiments some interesting features were revealed. 
EA  gain reactivity with  Raji  cells when they are transformed to  EAC1,  a 
reaction which clearly depends on the amount of C1 molecules (unpublished 
data) (25-30% rosettes were formed in case of 300 C1 molecules per EA); EAC14 
show 15% and EAC142  only about 3% rosette formation. The reactive site of 
EAC1  mediating binding  to  Raji  cells  is  either lost  during the  incubation 
needed to prepare the higher intermediates or is covered by C4 and C2.  The 
interaction between Raji cells and EAC1 could be due to the receptor for Clq, 
which  has  been  described for lymphoid cells  (21). At  the  same  time  it  is 
tempting to attribute a role to the C4, found in Raji cell membranes (22). It is 
not understood why EAC1  need higher C4  concentrations to respond in the 
bridging  assay  than  EAC14  and  especially than  EAC142.  The  question  is 
raised if possibly C2a  in the EAC142  plays a  role by either cleaving C4  or 
offering a site for C4 attachment. The sites to which the uncleaved C4 molecules 
are bound on Raji cells seem to be at least in part the C3 receptors, since C4 
binding is followed by reduced C3-dependent rosette formation (Fig.  6).  Such 
an assumption is supported by the earlier report that C4b can interfere with 
C3 receptor function (23). 
Based on the presence of Clq receptors on Raji cells (21) and the finding that 
EAC1  bound to Raji  cells,  it was not so  surprising that Raji  cells could be 
coated with soluble C1,  so that C1 in a dose-dependent manner would induce 
rosettes between Raji-C1  and EA in the bridge formation assay. In this case 
the interacting unit was C1 +  antibody. 
The bridge formation is not initiated solely within the complement system. 
The data show that the C42-enzyme can be replaced by an unspecific protease 
like trypsin. The effect is dependent on an optimal trypsin concentration (Fig. 
7)  and  an  optimal  incubation time  (Fig.  8).  C3  and C5  are better reaction 
partners  (65-75% rosettes) than C4,  which yields only a  limited amount of 
bridging units (15-20% rosette formation between Raji-C4  +  Em"-trypsin).  In 
view of the fact that in the fluid phase C3 can be acti.vated by trypsin (8,  16, 
17), similar activation processes might underly the trypsin-induced C3-, C5-, 
and  C4-bridges.  The schematic drawing in  Fig.  9  describes the mechanism 
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This mechanism  of complement-dependent  bridges between cells  may be of 
great biological significance. It has been demonstrated that C4 (22),  C1 (24), 
and factor B  (25)  are expressed in membranes.  Anti-C4 antibodies can inhibit 
the mixed lymphocyte reaction (22).  It  seems very conceivable that complement 
factors,  which are naturally exposed in cell  membranes may be activated by a 
proper protease on an adjacent cell leading to cell-cell  contact. Besides the 
possibility  of induction of cell-cell  contact through this  mechanism  it may be 
even more likely  that two cells,  which are in contact already through recogni- 
tion of  certain antigens on one cell  by certain receptors on the other, become 
tightly connected through complement bridges. Expression of  proteases on cell 
surfaces is described under different  circumstances.  Thus, macrophages upon 
activation show proteolytic activity on their surfaces (26-28).  An increase in 
protease activity  is also expressed in virus-infected cells  (29).  Our preliminary 
experiments with herpes virus-infected cells indicate that proteases  become 
expressed which are capable of  functioning in complement-dependent  cell-cell 
contact.  2 
The possibility  that a molecule on one cell  through alteration by enzymes on 
an adjacent cell acquires the capacity  to interlink these two cells is also 
discussed  for other systems. Reaggregation  of the cells of disrupted retinal 
tissues,  for  instance, may be related to such events (1;  for  additional references 
see 30). An important difference between such processes as reaggregation of 
cells of a  specific tissue and complement  bridges is that the complement 
bridges lack specificity,  because the labile groups of C3 or C5, for instance, 
bind to every cell  surface thus far investigated. 
Nevertheless this  process might have specificity  in as much as the comple- 
ment factors might be available only on certain cells  and/or the activating 
proteases could contribute to specificity  by limited representation on cells  and 
restricted  enzymatic activity. 
Summary 
Different leukocytes (Rail,  Daudi,  Rael  lymphoid cells;  human peripheral 
blood lymphocytes, and guinea pig granulocytes), which had been coated with 
C3 by incubation at 37~C for 20 rain in a  C3 solution, were demonstrated to 
form rosettes with erythrocytes  coated with complement components (EAC142). 
The percentage of rosettes was dependent on the amount of C3 present on the 
cells.  Loading of the lymphoid cells with C3  was a  time- and temperature- 
dependent process.  C3b was unable to serve the same purpose, although C3 
and  C3b  occupied the  C3  receptors on  the  lymphoid cells  to  a  comparable 
degree. C5 functions in a similar manner. The C~-enzyme can be re__e_placed by 
trypsin, so that bridging units may consist of C3  +  C42, C5  +  C42 or C3  + 
trypsin, and C5 + trypsin. Bridging units can be constructed also from C4 + C1. 
It  is  suggested that  enzymes on  one  cell  liberate  labile  binding  groups  of 
complement components on adjacent cells, thus inducing coupling of the two 
cells. The possibility is raised that this type of cell interlinkage may play a role 
in vivo, since there is accumulating evidence that complement components are 
expressed in the plasma membrane of different cells. 
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